Adaptive designs for dose-finding in non-cancer phase II trials: influence of early unexpected outcomes.
about
Developing a Bayesian adaptive design for a phase I clinical trial: a case study for a novel HIV treatment.New considerations in the design of clinical trials for amyotrophic lateral sclerosisInterplay of priors and skeletons in two-stage continual reassessment method.Small-sample behavior of novel phase I cancer trial designs.Using the continual reassessment method to estimate the minimum effective dose in phase II dose-finding studies: a case study.
P2860
Adaptive designs for dose-finding in non-cancer phase II trials: influence of early unexpected outcomes.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Adaptive designs for dose-find ...... of early unexpected outcomes.
@en
Adaptive designs for dose-find ...... of early unexpected outcomes.
@nl
type
label
Adaptive designs for dose-find ...... of early unexpected outcomes.
@en
Adaptive designs for dose-find ...... of early unexpected outcomes.
@nl
prefLabel
Adaptive designs for dose-find ...... of early unexpected outcomes.
@en
Adaptive designs for dose-find ...... of early unexpected outcomes.
@nl
P2860
P356
P1433
P1476
Adaptive designs for dose-find ...... of early unexpected outcomes.
@en
P2093
Sarah Zohar
P2860
P304
P356
10.1177/1740774508098788
P577
2008-01-01T00:00:00Z